Submitted by web@researchtop... on Tue, 08/27/2013 - 14:25
Home
CME test
CME information and faculty disclosures
Select publications
Case 3: 62-year-old man with Grade 1 FL and Stage IIA colon adenocarcinoma
5:23 minutes.
NEXT VIDEO:
Case 4: 60-year-old man with asymptomatic progression of CLL
Related videos:
BRIGHT and StiL NHL1-2003 studies of bendamustine/rituximab versus rituximab/chemotherapy in NHL
Rituximab schedule and maintenance in FL
Rituximab combined with lenalidomide (R squared) in untreated lymphoma
Type II anti-CD20 monoclonal antibody obinutuzumab in CLL
Novel agents in FL and CLL: BTK inhibitors
Targeted therapies in lymphomas and CLL: BTK, Syk and PI3Kδ inhibitors
Case 1: 59-year-old woman with Stage IE, Grade 3A FL
Case 2: 48-year-old woman diagnosed 10 years ago with FL
Case 4: 60-year-old man with asymptomatic progression of CLL